
APTOF P/E Ratio
P/E Ratio as of Jul 2, 2026: -0.16
Average-0.1450
Median-0.1400
Minimum-0.1600
Maximum-0.1400
-0.16
0.01 (6.67%)past month
The P/E ratio for APTOF is -0.16 as of Jul 2, 2026. This represents a increase of 14.29% compared to its 12-month average P/E ratio of -0.14. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Aptose Biosciences Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Aptose Biosciences Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Aptose Biosciences Inc to industry peers.
Aptose Biosciences Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Aptose Biosciences Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Aptose Biosciences Inc to industry peers.
APTOF P/E Ratio Insights
See Aptose Biosciences Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in APTOF
Order type
Buy in
Order amount
Est. shares
0 shares
APTOF P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jul 1, 2026 | $1.675 | -0.16 |
| Jun 1, 2026 | $1.68 | -0.16 |
| May 1, 2026 | $1.73 | -0.17 |
| Apr 1, 2026 | $1.71 | -0.16 |
| Mar 2, 2026 | $1.59 | -0.19 |
| Feb 2, 2026 | $1.67 | -0.20 |
| Jan 2, 2026 | $1.5385 | -0.19 |
APTOF End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | -0.16 | -11.11% |
| 2025 | -0.18 | +28.57% |
| 2024 | -0.14 | -56.25% |
| 2023 | -0.32 | -65.96% |
| 2022 | -0.94 | -49.19% |
| 2021 | -1.85 | — |
FAQs About Aptose Biosciences Inc (APTOF) P/E ratio
The latest P/E ratio of APTOF is -0.16, as of Jul 2, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Aptose Biosciences Inc’s last 12-month average P/E ratio is -0.14, compared to its current P/E ratio of -0.16. This reflects a increase of 14.29%.
Aptose Biosciences Inc’s current P/E ratio of -0.16 is higher than its last 12-month average P/E of -0.14. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Aptose Biosciences Inc’s average P/E ratio over the last 3 years is -0.17. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Aptose Biosciences Inc’s average P/E ratio over the last 5 years is -0.85. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.